| CAS ID: | 1969264-35-4 |
| Molecular Formula: | C50H55F3N4O9 |
| Molecular Weight: | 913 g/mol |
| Monoisotopic Mass: | 912.392 g/mol |
| Class: | Small Molecule |
| Natural Product: | No |
| Other Names: | |
| Analysis: | N/A |
| InChI: | InChI=1S/C26H27F3N2O6.C24H28N2O3/c1-24(2,13-33)22-8-14-7-18(17(27)10-19(14)31(22)11-16(34)12-32)30-23(35)25(5-6-25)15-3-4-20-21(9-15)37-26(28,29)36-20;1-23(2,3)16-11-17(24(4,5)6)20(27)12-19(16)26-22(29)15-13-25-18-10-8-7-9-14(18)21(15)28/h3-4,7-10,16,32-34H,5-6,11-13H2,1-2H3,(H,30,35);7-13,27H,1-6H3,(H,25,28)(H,26,29)/t16-;/m1./s1 | See All |
| InChI Key: | NETGOEWJJZQLCO-PKLMIRHRSA-N | |
| Smiles: | See All | |
| Molfile: |
Trial Record 1
| ClinicalTrial ID | NCT02951182 | Disease | Cystic fibrosis |
| Phase | Phase 2 | Status | Completed |
| First Received | November 1, 2016 | Last Verified | August 15, 2018 |
| Sponsor | Vertex Pharmaceuticals Incorporated | ||
| PubChem: | 72722243.0 |
| ChEMBL: |